Peterlini et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A717
http://www.icm-experimental.com/content/3/S1/A717
POSTER PRESENTATION Open Access
Stability of vancomycin hydrochloride solutions in high concentration and extended time of infusion
MA Peterlini*, APS Barbosa, M Pedreira From ESICM LIVES 2015
Berlin, Germany. 3-7 October 2015
Introduction
Vancomycin hydrochloride is an antimicrobial commonly used and studied in the treatment of patient with health-care-associated infections. However, there are few studies related to this drug stability during administration. In intensive care units, mainly pediatric and neonatal, the clinical conditions and specific needs of patients may require longer time of vancomycin hydrochloride infusion or concentrated solutions, different of literature recommendations of a final dilution of 2.5 to 5.0 mg/ml in one hour of infusion. There is a lack of evidences for nursing practice regarding vancomycin hydrochloride infusion in higher concentration and longer time.
Objectives
To determine the stability of vancomycin hydrochloride solutions at a concentration of 10mg/mL, according to two infusion periods.
Methods
Experimental study that simulated the nursing clinical practice of intravenous administration of vancomycin hydrochloride solutions at a concentration of 10mg/ml. The stability was determined by high-performance liquid chromatography (HPLC) and pH in two conditions of temperature, 22C( 1) and 37C( 1), and two exposure
times, 60 and 120 minutes. The concentration and pH were monitored after drug reconstitution with water for injection, after dilution with sodium chloride 0.9% and after 60 and 120 minutes of infusion. The sample was collected in triplicate to pH analyzes, and each triplicate was analyzed by HPLC in quintuplicate to determine a final concentration. Data were analyzed by using the mean and standard deviation (m SD).
Results
Of the 60 pH analyzed values of vancomycin solutions, no substantial variations were observed (Tables 1). HPLC analyzes resulted in 120 measured concentrations; at 22C( 1) an increased concentration of 4.03% and21.11% were identified, at 60 and 120 minutes, respectively (Table 1). Solutions exposed to 37C( 1) resulted in an increased concentration of 4.59% in 60 minutes and a decreased concentration of 10.28% in 120 minutes (Table 1). It is important to highlight that medication preparation was accomplished in syringes and the measured initial concentrations were different than 10 mg/mL.
Conclusions
Vancomycin hydrochloride solutions diluted at 10 mg/ml presented a clinically relevant alteration when infused during 120 min, despite the analyzed temperature.
Table 1. Concentration, variation ratio and pH
Experimental situations Concentration (mg/mL) Concentration variation pH(unit)
Initial Final (%) Initial Final 22C( 1)60 minuts 9.17 0.56 9.54 1.32 4.03 3.59 0.03 3.64 0.02 22C( 1)120 minuts 8.43 0.57 10.21 1.41 21.11 3.63 0.05 3.65 0.01 37C( 1)60 minuts 9.57 0.74 10.01 0.45 4.59 3.62 0.02 3.65 0.01 37C( 1)120 minuts 10.71 1.60 9.61 1.33 10.28 3.61 0.02 3.63 0.02
Federal University of So Paulo, Pediatric Nursing, So Paulo, Brazil
2015 Peterlini et al.; This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0
Web End =http:// http://creativecommons.org/licenses/by/4.0
Web End =creativecommons.org/licenses/by/4.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Peterlini et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A717
http://www.icm-experimental.com/content/3/S1/A717
Page 2 of 2
Grant AcknowledgmentNational Council for Scientific and Technological Development - CNPq 462183/2014-9
Published: 1 October 2015
doi:10.1186/2197-425X-3-S1-A717Cite this article as: Peterlini et al.: Stability of vancomycin hydrochloride solutions in high concentration and extended time of infusion. Intensive Care Medicine Experimental 2015 3(Suppl 1):A717.
Submit your manuscript to a
journal and benet from:
7 Convenient online submission7 Rigorous peer review7 Immediate publication on acceptance7 Open access: articles freely available onlihttp://www.springeropen.com/
Web End =ne 7 High visibility within the eld7 Retaining the copyright to your article
Submit your next manuscript at 7 http://www.springeropen.com/
Web End =springeropen.com
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
The Author(s) 2015
Abstract
Issue Title: ESICM LIVES 2015
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer